Today, we are not going to talk about professional and technical theories, so let’s discuss in big words how far hepatitis B is from liver cancer. Chronic hepatitis B may indeed induce liver cancer China is a large country with hepatitis B. Most of the population may have been exposed to hepatitis B virus in their lifetime, and about 10% of them are infected and carry the hepatitis B virus. So, can hepatitis B really cause liver cancer? The answer is, yes. Hepatitis B is a war that takes place on the liver. The battle between the hepatitis B virus and the body’s immune cells is too intense and inevitably destroys the “battlefield”, causing damage to the liver and cellular necrosis. Chronic hepatitis B is such a tug-of-war between you and me. Long-term warfare causes repeated inflammation and necrosis of liver tissues and fibrosis of the liver in the process of self-repair, which gradually leads to cirrhosis of the liver. Cirrhosis is a high risk factor for liver cancer, and about 80-90% of liver cancer patients have a background of hepatitis B as well as cirrhosis. In addition, genetic mutations during the accelerated regeneration of liver cells may also induce liver cancer. Chronic hepatitis B gradually develops into cirrhosis and finally cancer, which is the most common “hepatitis B trilogy” pathogenesis pattern. Only a small percentage of people end up with liver cancer. Seeing this, many hepatitis B patients may panic, is this a fate that cannot be escaped? Don’t be too nervous first, although the population base of hepatitis B virus infected people is relatively large and the occurrence of liver cancer is indeed related to hepatitis B, only a small number of people actually end up with liver cancer. As we mentioned earlier, about 10% of the population in China is infected with hepatitis B virus and carries it, and a small percentage of them will develop chronic hepatitis B. How large is this percentage? How large is this percentage? According to medical data, 90% and 25%-30% of patients infected with the hepatitis B virus during the perinatal period and infancy, respectively, will develop chronic infection, while only 5%-10% of those infected after the age of 5 will develop chronic infection. And thanks to the advent of the hepatitis B vaccine and timely mother-to-child interruption, the chances of infants and children becoming infected with hepatitis B virus are decreasing. Of these chronic hepatitis B patients, only a small percentage will develop cirrhosis (liver fibrosis). Finally, only about 10 percent of patients with cirrhosis will develop primary liver cancer. What is the solution to stop hepatitis B cancer? Not all people infected with the hepatitis B virus will eventually develop cirrhosis and liver cancer. Only cases of recurrent hepatitis B, decreased immunity and genetic mutations are prone to develop cirrhosis and liver cancer. To stop hepatitis B from developing into cirrhosis and liver cancer, the key is to control hepatitis B in time. Hepatitis B virus infection should be taken seriously, but there is no need to talk about tiger and extreme panic. So how can we avoid the occurrence of liver cancer? First, pay attention to vaccination to avoid hepatitis B virus infection. Our country has done a lot of basic work on this point, such as popularizing hepatitis B vaccination for newborns, so that most children are no longer infected with hepatitis B virus. Second, reasonable treatment to avoid recurrent attacks of chronic hepatitis B. Hepatitis B virus is not scary, and only a small percentage of HBsAg (hepatitis B surface antigen) positive patients develop primary liver cancer. What is scary is that the continuous infection and replication of hepatitis B virus and recurrent attacks of chronic hepatitis make the immunity of human body decrease, which leads to liver fibrosis and inevitably liver cirrhosis, and the possibility of liver cancer due to genetic mutation in the process of accelerated regeneration of liver cells increases greatly. Therefore, proper treatment and control are very important. Thirdly, taking antiviral drugs and using free radical scavengers. In addition to anti-hepatitis B virus drugs, some studies in recent years have found that the free radical scavenging ability of chronic liver disease decreases, and it has been widely accepted to use free radical scavengers to prevent liver cancer and reduce the cancer caused by free radical attack on liver cells. Free radical scavengers mainly include proanthocyanidins, apple polyphenols, lipoic acid, vitamin E, vitamin C, etc. Furthermore, change your lifestyle and drink less alcohol at night. Liver cancer is basically an environmental disease and a lifestyle disease, so there is much we can do here to improve our lifestyle. The common bad lifestyles include long-term fatigue. As the old saying goes: accumulation of fatigue becomes disease. Fatigue is the source of all diseases, especially staying up late at night, which has a huge damaging effect on the liver. Excessive alcohol consumption. Wine is poison, figuratively speaking, drunk once is suffering from a hepatitis, in the long run, the liver can withstand it? Bad mood. As mentioned earlier, anger hurts the liver, and bad moods can also cause great damage to the liver. Finally, people at risk should have their fetoprotein and liver ultrasound checked every six months. This is especially true for patients with “small triplets”, which are generally acute hepatitis B virus infections that tend to recover. In addition, there are chronic hepatitis B and chronic hepatitis B virus carriers. The most common characteristics of these people are the so-called “healthy carriers”, whose liver function is basically normal, their laboratory tests are “major triple-positive” or “minor triple-positive”, and they have no signs of liver discomfort. There are no signs of liver discomfort and other symptoms. Since their clinical symptoms are not obvious, they are easy to be ignored and therefore have a greater potential risk to human health. For people over 35 years old who are positive for hepatitis B surface antigen, have chronic hepatitis, have cirrhosis of the liver for more than 5 years, and have a family history of liver cancer in three generations of their immediate family members, testing fetoprotein and liver ultrasound once every six months is the most effective way to detect liver cancer at an early stage. The above points are easy to understand and not difficult to do, so that we can try to avoid the occurrence of liver cancer and improve the treatment effect of liver cancer.